Tandem糖尿病护理股份在Robert W. Baird降低价格目标后跌至30.60美元。 Tandem Diabetes Care shares fell to $30.60 after a price target cut by Robert W. Baird.

在Robert W. Baird将其价格目标从39美元降至37美元之后,坦迪姆糖尿病护理股份下降了2.72美元至30.60美元,保持中性评级。 Tandem Diabetes Care (TNDM) shares dropped $2.72 to $30.60 after Robert W. Baird cut its price target from $39 to $37, maintaining a neutral rating. 其他分析师有不同的意见,UBS升级为"持有",富国银行将目标提高到55美元,加拿大皇家银行设定65美元的目标,评级"超越". Other analysts have varied opinions, with UBS upgrading to "hold," Wells Fargo raising its target to $55, and Royal Bank of Canada setting a $65 target with an "outperform" rating. 总而言之,该股票的评分是“机动购买”,平均价格目标为54.25美元。 Overall, the stock holds a consensus rating of "Moderate Buy" and an average price target of $54.25.